Zobrazeno 1 - 10
of 54
pro vyhledávání: '"Janice Lamb"'
Autor:
Yves Allenbach, Andrew L. Mammen, Olivier Benveniste, Werner Stenzel, Anthony Amato, Audrey Aussey, Jan De Bleecker, Ingrid de Groot, Marianne de Visser, Hans Goebel, Baptiste Hervier, Norina Fischer, David Hilton-Jones, Janice Lamb, Ingrid Lundberg, Andrew Mammen, Tahseen Mozaffar, Ichizo Nishino, Alan Pestronk, Ulrike Schara, Werner Stenzelr
Publikováno v:
Neuromuscular Disorders. 28:87-99
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9039208abdd48cf774fe587b9153c934
https://doi.org/10.1016/j.nmd.2017.09.016
https://doi.org/10.1016/j.nmd.2017.09.016
Publikováno v:
Blood Coagulation & Fibrinolysis
Risk for thrombotic events with factor IX replacement therapy in patients with haemophilia B remains a concern for patients, those who treat them, and regulatory agencies, based on experience with early use of prothrombin complex concentrates. The cu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87fe2ecf3a7719d74bc11a8b9fd58da2
https://pubmed.ncbi.nlm.nih.gov/29135476
https://pubmed.ncbi.nlm.nih.gov/29135476
Publikováno v:
BJU International. 106:674-680
Study Type – Therapy (RCT) Level of Evidence 1b OBJECTIVES To evaluate the efficacy and safety of the phosphodiesterase type 5 inhibitor UK-369,003 for the treatment of lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ef5aa3d0dedae1204e00792dec690fa
https://doi.org/10.1111/j.1464-410x.2010.09204.x
https://doi.org/10.1111/j.1464-410x.2010.09204.x
Publikováno v:
Movement Disorders. 22:476-482
To assess the safety and efficacy of sumanirole, a highly selective dopamine agonist, versus placebo and demonstrate its noninferiority to ropinirole, 614 patients with early Parkinson's disease (PD) were treated with sumanirole, 1 to 16 mg/day; ropi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e68abc9876eee5253ccc52f8f066f004
https://doi.org/10.1002/mds.21361
https://doi.org/10.1002/mds.21361
Autor:
Mark Morris, Janice Lamb, Zhi-Cheng Jing, Lorraine Collings, Kelly Chin, Gwyn D'Souza, Diane Zwicke, John G. Teeter, Gary Burgess
Publikováno v:
C63. MANAGEMENT OF PULMONARY HYPERTENSION.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a89703cb1a3b62941e92301292f70107
https://doi.org/10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a4805
https://doi.org/10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a4805
Autor:
Gary Burgess, Diane Zwicke, Gwyn D'Souza, Kelly Chin, Zhi-Cheng Jing, John G. Teeter, Janice Lamb, Lorraine Collings
Publikováno v:
C63. MANAGEMENT OF PULMONARY HYPERTENSION.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5d0935e9c0c597b294ccebe1a4c43601
https://doi.org/10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a4812
https://doi.org/10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a4812
Autor:
Janice Lamb
Publikováno v:
Cognitive Behaviour Therapy Case Studies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::12a44edf4d298cd41a450e518921bcc7
https://doi.org/10.4135/9781446289037.n9
https://doi.org/10.4135/9781446289037.n9
Autor:
Scott Haughie, Peter M. Ellis, Nihad Tamimi, Anna Crossland, Francois A. Giuliano, Janice Lamb
Publikováno v:
BJU international. 106(5)
Study Type – Therapy (RCT) Level of Evidence 1b OBJECTIVES To evaluate the efficacy and safety of the phosphodiesterase type 5 inhibitor, UK-369,003 modified release (MR), for the treatment of storage lower urinary tract symptoms (LUTS) in men with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08712f5803db07247599a71d43bc0f37
https://pubmed.ncbi.nlm.nih.gov/20151971
https://pubmed.ncbi.nlm.nih.gov/20151971
Publikováno v:
Movement disorders : official journal of the Movement Disorder Society. 22(4)
The aims of this study were to assess the safety, tolerability, and efficacy of sumanirole, a highly selective D2 dopamine receptor agonist, versus placebo in subjects with advanced Parkinson's disease (PD), and to demonstrate noninferiority of suman
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::089299299d7cfded0d83161b1aa1612b
https://pubmed.ncbi.nlm.nih.gov/17115380
https://pubmed.ncbi.nlm.nih.gov/17115380
Autor:
Amanda Ellis, Janice Lamb, Diego Garcia-Borreguero, Gary Layton, Alieu Adams, Mark Versavel, John W. Winkelman, Mark Morris
Publikováno v:
Sleep medicine. 8(2)
Objective To compare the efficacy, safety and tolerability of sumanirole with placebo in patients with idiopathic restless legs syndrome (RLS). Methods In this double-blind, placebo-controlled, randomized, parallel-group, dose–response study, 270 p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4aa53440a9f2a0d1fa18f9712880a7e3
https://pubmed.ncbi.nlm.nih.gov/17239657
https://pubmed.ncbi.nlm.nih.gov/17239657